STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
- Grade 3b Follicular Lymphoma
- +15 more
- Laboratory Biomarker Analysis
- +2 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-17
Feb 17, 2022C
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +3 more
- (no location specified)
2021-07-20
Jul 20, 2021W
Terminated
- Follicular Lymphoma
- Mantle Cell Lymphoma
- New York, New YorkWeill Cornell Medicine
2021-09-20
Sep 20, 2021S
Recruiting
- Follicular Lymphoma
- 12 Gy in 6 daily fractions
- Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
2022-03-10
Mar 10, 2022S
Terminated
- Follicular Lymphoma
- Lymphoma, Follicular
- Zevalin Therapeutic Regimen
- R-CVP
- Jacksonville, Florida
- +5 more
2021-12-16
Dec 16, 2021D
Recruiting
- Follicular Lymphoma
- Rituximab
- +2 more
- Boston, MassachusettsDana Farber Cancer Institute
2022-03-14
Mar 14, 2022B
Recruiting
- Follicular Lymphoma and Marginal Zone Lymphoma
- Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
- lenalinomide
- Beijing, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
2022-02-13
Feb 13, 2022J
Recruiting
- Follicular Lymphoma
- Loncastuximab tesirine
- Rituximab
- Miami, FloridaUniversity of Miami
2022-02-22
Feb 22, 2022N
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022H
Not yet recruiting
- Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
- Standard
- Experimental
- (no location specified)
2021-09-12
Sep 12, 2021D
U
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Acalabrutinib
- Axicabtagene Ciloleucel
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022N
Active, not recruiting
- Non Hodgkin Lymphoma
- +2 more
- Ostrava-, Porubá, Czechia
- +1 more
2022-02-11
Feb 11, 2022C
Not yet recruiting
- Recurrent Follicular Lymphoma
- Refractory Follicular Lymphoma
- Tazemetostat
- +2 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-16
Feb 16, 2022U
Recruiting
- Follicular Lymphoma (Gastric or Duodenal)
- Marginal Zone Lymphoma (Gastric or Duodenal)
- Radiation Therapy
- Münster, North Rhine-Westphalia, GermanyDepartment of Radiation Oncology
2021-12-01
Dec 1, 2021N
Recruiting
- Follicular Lymphoma
- Bethesda, MarylandNational Institutes of Health Clinical Center
2021-04-28
Apr 28, 2021E
Recruiting
- Grade 1 Follicular Lymphoma
- +7 more
- Acalabrutinib
- +3 more
- Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
2021-12-07
Dec 7, 2021I
Not yet recruiting
- Follicular Lymphoma ( FL)
- Marginal Zone Lymphoma (MZL)
- parsaclisib
- +2 more
- (no location specified)
2022-02-07
Feb 7, 2022C
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
- Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
2022-01-24
Jan 24, 2022M
Active, not recruiting
- Lymphoma
- +3 more
- Basking Ridge, New Jersey
- +5 more
2021-06-11
Jun 11, 2021C
Recruiting
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Determination of COVID-19 vacciantion efficacy
- Rouen, FranceCentre Henri Becquerel
2021-06-07
Jun 7, 2021C
Not yet recruiting
- Diffuse Large Cell Diffuse Lymphoma
- Follicular Lymphoma
- Questionnaires
- Collection of clinical data and treatments
- Dijon, FranceChu Dijon Bourogne
2021-04-22
Apr 22, 2021U
Recruiting
- Follicular Lymphoma
- Venetoclax
- +2 more
- Chicago, IllinoisUniversity of Chicago Medical Center
2021-11-12
Nov 12, 2021C
Terminated
- Follicular Lymphoma
- New York, New YorkColumbia University Medical Center
2021-06-28
Jun 28, 2021N
Suspended
- Follicular Lymphoma
- +4 more
- Obinutuzumab
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022